130 related articles for article (PubMed ID: 12370238)
1. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
Veinot JP
Circulation; 2002 Oct; 106(15):e73; author reply e73. PubMed ID: 12370238
[No Abstract] [Full Text] [Related]
2. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
Sachdev B; Takenaka T; Teraguchi H; Tei C; Lee P; McKenna WJ; Elliott PM
Circulation; 2002 Mar; 105(12):1407-11. PubMed ID: 11914245
[TBL] [Abstract][Full Text] [Related]
3. The heart in Anderson Fabry disease.
Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.
Chimenti C; Pieroni M; Morgante E; Antuzzi D; Russo A; Russo MA; Maseri A; Frustaci A
Circulation; 2004 Aug; 110(9):1047-53. PubMed ID: 15313943
[TBL] [Abstract][Full Text] [Related]
5. Fabry cardiomyopathy in the female confirmed by endomyocardial biopsy.
Broadbent JC; Edwards WD; Gordon H; Hartzler GO; Krawisz JE
Mayo Clin Proc; 1981 Oct; 56(10):623-8. PubMed ID: 6268901
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
[TBL] [Abstract][Full Text] [Related]
7. Endomyocardial biopsy in Anderson-Fabry disease: The key in uncertain cases.
Tschöpe C; Dominguez F; Canaan-Kühl S; Blaschke D; Kühl U; Pieske B; Haverkamp W
Int J Cardiol; 2015; 190():284-6. PubMed ID: 25932808
[No Abstract] [Full Text] [Related]
8. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin.
Pisani A; Riccio E; Cianciaruso B; Imbriaco M
J Nephrol; 2011; 24(6):806-8. PubMed ID: 22058028
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.
Havndrup O; Christiansen M; Stoevring B; Jensen M; Hoffman-Bang J; Andersen PS; Hasholt L; Nørremølle A; Feldt-Rasmussen U; Køber L; Bundgaard H
Eur J Heart Fail; 2010 Jun; 12(6):535-40. PubMed ID: 20498269
[TBL] [Abstract][Full Text] [Related]
10. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.
Elliott P; Baker R; Pasquale F; Quarta G; Ebrahim H; Mehta AB; Hughes DA;
Heart; 2011 Dec; 97(23):1957-60. PubMed ID: 21890869
[TBL] [Abstract][Full Text] [Related]
12. Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.
Linthorst GE; Poorthuis BJ; Hollak CE
J Am Coll Cardiol; 2008 May; 51(21):2082; author reply 2082-3. PubMed ID: 18498967
[No Abstract] [Full Text] [Related]
13. Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy.
Yano T; Oshima H; Miki T; Tanaka M; Muranaka A; Osanami A; Takahashi F; Miura T
Int J Cardiol; 2016 Jan; 203():136-7. PubMed ID: 26512827
[No Abstract] [Full Text] [Related]
14. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.
Nagao Y; Nakashima H; Fukuhara Y; Shimmoto M; Oshima A; Ikari Y; Mori Y; Sakuraba H; Suzuki Y
Clin Genet; 1991 Mar; 39(3):233-7. PubMed ID: 1645238
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.
Monserrat L; Gimeno-Blanes JR; Marín F; Hermida-Prieto M; García-Honrubia A; Pérez I; Fernández X; de Nicolas R; de la Morena G; Payá E; Yagüe J; Egido J
J Am Coll Cardiol; 2007 Dec; 50(25):2399-403. PubMed ID: 18154965
[TBL] [Abstract][Full Text] [Related]
16. Detection of Urinary Mulberry Bodies Leads to Diagnosis of Fabry Cardiomyopathy: A Simple Clue in the Urine Sediment.
Yano T; Takahashi R; Yamashita T; Nagano N; Ishikawa A; Sakurai A; Maruyama H; Miura T
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203563
[No Abstract] [Full Text] [Related]
17. Hypertrophic obstructive cardiomyopathy due to Fabry's disease.
Colucci WS; Lorell BH; Schoen FJ; Warhol MJ; Grossman W
N Engl J Med; 1982 Oct; 307(15):926-8. PubMed ID: 6810178
[No Abstract] [Full Text] [Related]
18. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
Demontis R
Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy and Anderson-Fabry disease: unravelling septal hypertrophy with T1-mapping CMR.
Edwards NC; Teoh JK; Steeds RP
Eur Heart J; 2014 Jul; 35(28):1896. PubMed ID: 24713641
[No Abstract] [Full Text] [Related]
20. Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.
Seo J; Kim M; Hong GR; Kim DS; Son JW; Cho IJ; Shim CY; Chang HJ; Ha JW; Chung N
J Hum Genet; 2016 Sep; 61(9):775-80. PubMed ID: 27225851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
